Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
E2 · 17beta-Estradiol · Oestradiol
Estradiol tests quantify the concentration of 17β-estradiol, a primary estrogen hormone, in the blood.
Reference ranges vary by sex and menstrual cycle phase. Estradiol levels are higher in females and fluctuate during the menstrual cycle.
Estradiol (E2), also known as 17β-estradiol or oestradiol, is a key estrogen hormone predominantly produced in the ovaries, with smaller amounts synthesized in the adrenal glands and testes. It plays a crucial role in regulating the reproductive system, influencing the menstrual cycle, and maintaining pregnancy. In males, estradiol is involved in modulating libido, erectile function, and spermatogenesis. Clinically, estradiol levels are significant in diagnosing and managing conditions such as menopause, polycystic ovary syndrome (PCOS), and certain forms of cancer. Elevated estradiol levels can indicate estrogen-producing tumors or liver disease, while low levels are often associated with menopause, hypogonadism, or anorexia. For athletes and biohackers, estradiol is relevant due to its role in energy balance, bone density, and muscle mass maintenance. Researchers found that estradiol influences metabolic health by interacting with estrogen receptors in various tissues, affecting fat distribution and thermogenesis. However, measuring estradiol levels can be influenced by factors such as time of day, menstrual cycle phase, and recent hormone therapy. Researchers observed that estradiol levels fluctuate throughout the day and cycle, necessitating standardized testing conditions for accurate assessment.
Klinische Bedeutung
Elevated estradiol levels may indicate estrogen-producing tumors, liver disease, or hyperthyroidism. Reduced levels are often associated with menopause, ovarian failure, or hypogonadism.
Progressively rising estradiol levels may indicate estrogen-producing tumors or liver dysfunction. Re-test in 4 weeks if elevated.
Progressively falling estradiol levels may suggest ovarian failure or menopause.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on hormone therapy.
Estradiol levels vary throughout the day; morning samples are preferred for consistency.
Testing Frequency
Annually for women over 50 or those on hormone therapy.
Correlated with
Current research suggests that robust reference intervals for estradiol (E2) in women, particularly during the menstrual cycle and in the context of hormone therapy, remain incomplete. Researchers have not yet established optimal E2 targets for various clinical scenarios, including menopausal symptom management and gender-affirming care. Additionally, unanswered clinical questions include the long-term effects of E2 on metabolic health and its role in male physiology, particularly regarding the implications of estrogen signaling in nonreproductive tissues.
968
Total Citations
8
Human/RCT
3.8
Avg. Influence
2024
Latest
This review explored the role of estrogens, including 17β-estradiol (E2), in male physiology. Researchers observed that E2 is present in males and regulates various reproductive and non-reproductive organs. The study suggests that estrogen signaling is crucial for normal male reproductive function and may have broader physiological implications.
This review compared the neuroendocrinology of menopause in rodents and humans. Researchers found similarities in ovarian aging and hormonal changes, noting that hypothalamic impairments in estrogen signaling are prominent in aging rodents but less so in peri-menopausal women. The study suggests ongoing research into the effects of hormone therapy on cognitive health.
This review examined the role of estrogens, particularly 17β-estradiol (E2), in regulating energy balance and metabolic health. Researchers found that estrogen deficiency is linked to obesity and metabolic disorders, which can be improved with estrogen therapy. The study highlighted the importance of estrogen signaling in both males and females and identified gaps in understanding metabolic diseases.
Researchers examined the interaction between estradiol (E2) and progesterone (P) in breast cells, finding that E2 promotes cell growth while P can act as an antagonist. They noted that proper hormonal balance is crucial for normal breast development and that prolonged unopposed estrogen may contribute to breast cancer risk. The study underscores the importance of hormonal regulation in breast health.
This review discussed how 17β-estradiol (E2) influences memory formation through epigenetic mechanisms. Researchers found that E2 enhances memory in female mice by affecting histone modifications and DNA methylation in the hippocampus. The study highlights the complexity of epigenetic regulation and the need for further research in this area.
This study investigated the ecotoxicological effects of 17β-estradiol (E2) on chlorella algae, finding significant growth inhibition at certain concentrations. Researchers observed that E2 affected chlorophyll levels and enzymatic activity in the algae. The study also noted that chlorella could effectively degrade E2, highlighting its potential role in mitigating estrogen pollution in aquatic environments.
Researchers observed that chronic 17β-estradiol (E2) treatment in aged female rats prevented age-related increases in calcium channel activity, a biomarker of brain aging. They found that E2 treatment led to decreased expression of specific calcium channel subunits in the hippocampus. This suggests that E2 may have protective effects on cognitive health in aging females.
This review summarized insights from rat models of 17β-estradiol (E2)-induced mammary cancer. Researchers found that E2 plays a significant role in breast cancer development through estrogen receptors and associated mechanisms. The study emphasizes the relevance of these models for understanding breast cancer etiology and prevention.
This review highlighted the potential clinical applications of measuring estrone sulfate (E1S), an estrogen biomarker. Researchers found that E1S could be useful in risk stratification for various cancers and monitoring hormonal therapy responses. The study calls for further investigation into the clinical utility of E1S measurements.
Researchers proposed that the epoxidation of 17β-estradiol (E2) may play a role in breast cancer initiation. They presented evidence that E2 can form DNA adducts, which could contribute to carcinogenesis. The study also explored the potential of dietary fats and tamoxifen in preventing E2 epoxidation, suggesting new avenues for breast cancer prevention.
Research publications about Estradiol over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer